Home
Jenburkt Pharmaceuticals Ltd Quarterly Result

Jenburkt Pharmaceuticals Ltd
NSE: JENBURKTPHARMA
Net Profit - Last Quarter
Jenburkt Pharmaceuticals Ltd Quarterly Results Key Highlights
- The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 38.47 crore as compare to the Sep '24 revenue of ₹ 43.07 crore.
- This represent the decline of -10.68%a1# The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 10.4 crore as compare to the Sep '24 ebitda of ₹ 13.28 crore.
- This represent the decline of -21.69%a1# The net profit of Jenburkt Pharmaceuticals Ltd for the Dec '24 is ₹ 6.51 crore as compare to the Sep '24 net profit of ₹ 9.6 crore.
- This represent the decline of -32.19%a1#.
Jenburkt Pharmaceuticals Ltd Quarterly Results Analysis
Market Price of Jenburkt Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 1124.7 |
16 Apr 2025 | 1133.45 |
15 Apr 2025 | 1092.3 |
11 Apr 2025 | 1042.85 |
09 Apr 2025 | 1009.85 |
08 Apr 2025 | 1018 |
07 Apr 2025 | 1014 |
04 Apr 2025 | 1045.65 |
03 Apr 2025 | 1071.3 |
02 Apr 2025 | 1040 |
Historical Revenue of Jenburkt Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Jenburkt Pharmaceuticals Ltd
Historical EBITDA of Jenburkt Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Jenburkt Pharmaceuticals Ltd
Historical Net Profit of Jenburkt Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals Ltd News Hub
Jenburkt Pharmaceuticals to announce Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November
Read more
29 Oct 24
Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter
Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2
Read more
05 Nov 24
Jenburkt Pharmaceuticals to table results
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January
Read more
21 Jan 25
Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter
Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20
Read more
29 Jan 25